Table 1.
Characteristics of the Patients Included in the Study
| Characteristic | Patients with UC (n = 6) |
|---|---|
| Mean age ± SD, y | 47.7 ± 13.3 |
| Sex (male/female) | 4/2 |
| Mean duration of disease ± SD, y | 12.0 ± 11.6 |
| Disease location, n | |
| Proctitis | 2 |
| Left-sided colitis | 1 |
| Extensive colitis | 3 |
| Ongoing treatments, n | |
| 5-ASA | 5 |
| Azathioprine, 6-MP | 2 |
| Anti-TNF therapy | 2 |
| Anti-α4β7 integrin therapy | 1 |
| PSL | 2 |
| Median Lichtiger index (range) | 1 (0-1) |
| Median UCEIS (range) | 1.5 (0-3) |
| Mean CRP ± SD, mg/dL | 0.17 ± 0.21 |
5-ASA, 5-Aminosalicylic acid; CRP, C-reactive protein; 6-MP, mercaptopurine; PSL, prednisolone; SD, standard deviation; TNF, tumor necrosis factor; UC, ulcerative colitis; UCEIS, Ulcerative Colitis Endoscopic Index of Severity.